- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medicure Inc (MPH)
Medicure Inc stock price live, this page displays TSXV MPH stock exchange data. View the MPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medicure Inc real time stock price chart below.
What Is the Medicure Inc Stock Price Today?
The Medicure Inc stock price today is 1.3000.
What Is the Stock Symbol for Medicure Inc?
The stock symbol for Medicure Inc is "MPH."
What Stock Exchange Does Medicure Inc Trade On?
Medicure Inc is listed and trades on the TSXV stock exchange.
Is Medicure Inc a Good Stock to Buy?
Determining whether Medicure Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MPH quote. (ISIN: CA58469E4085)
What Is the Medicure Inc Stock Price Today?
The Medicure Inc stock price today is 1.3000.
What Is the Stock Symbol for Medicure Inc?
The stock symbol for Medicure Inc is "MPH."
What Stock Exchange Does Medicure Inc Trade On?
Medicure Inc is listed and trades on the TSXV stock exchange.
Is Medicure Inc a Good Stock to Buy?
Determining whether Medicure Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MPH quote. (ISIN: CA58469E4085)
1.3000
0.0000(0.00%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3000
1.3000
52 wk Range
0.8500
1.4300
Earnings results expected in 7 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.30001.3000
52 wk Range
0.85001.4300
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MPH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low revenue valuation multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Medicure Inc Earnings Call Summary for Q2/2026
- Q2 revenue rose 10.4% YoY to CAD 7.4M driven by ZYPITAMAG growth and pharmacy operations; net loss widened to CAD 1.4M from CAD 786K.
- Adjusted EBITDA turned positive at CAD 172K vs. negative CAD 28K prior year; AGGRASTAT revenue plunged 61.1% due to generic competition.
- Pharmacy network generated CAD 5.9M (79.9% of total revenue); West Olympia contributed first full quarter post-2025 acquisition.
- Loss driven by CAD 864K CMS rebate liability and CAD 608K R&D investment in phase III MC-1 rare disease program with FDA Fast Track status.
- No formal guidance issued; management prioritizes ZYPITAMAG expansion, pharmacy synergies, and MC-1 advancement amid CAD 1.8M cash position.
Last Updated: 08/17/2026, 09:44 PM
Read Full TranscriptEarnings
Latest Release
Aug 14, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare MPH to Peers and Sector
Metrics to compare | MPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −2.5x | −0.3x | |
PEG Ratio | 0.00 | 0.04 | 0.00 | |
Price/Book | 1.2x | 1.6x | 2.6x | |
Price / LTM Sales | 0.4x | 2.7x | 3.1x | |
Upside (Analyst Target) | - | 92.9% | 50.4% | |
Fair Value Upside | Unlock | −5.5% | 6.4% | Unlock |
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order, and online pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Medicure (MPH) Stock Price Today?
The Medicure stock price today is 1.3000 CAD.
What Stock Exchange Does Medicure Trade On?
Medicure is listed and trades on the TSX Venture Exchange.
What Is the Stock Symbol for Medicure?
The stock symbol for Medicure is "MPH."
What Is the Medicure Market Cap?
As of today, Medicure market cap is 13.5700M CAD.
What Is Medicure's Earnings Per Share (TTM)?
The Medicure EPS (TTM) is -0.7225.
When Is the Next Medicure Earnings Date?
Medicure will release its next earnings report on Aug 26, 2026.
From a Technical Analysis Perspective, Is MPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Medicure Stock Split?
Medicure has split 1 times.
How Many Employees Does Medicure Have?
Medicure has 38 employees.
What is the current trading status of Medicure (MPH)?
As of Aug 19, 2026, Medicure (MPH) is trading at a price of 1.3000 CAD, with a previous close of 1.3000 CAD. The stock has fluctuated within a day range of 1.3000 CAD to 1.3000 CAD, while its 52-week range spans from 0.8500 CAD to 1.4300 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.